Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Login

|

2025
February 26
5:30 pm -
7:30 pm
EST
Seminar
Boston, MA, USA
The Life Science IP Playbook: What Life Science Companies Really Need to Know
LES USA & Canada

Join LES USA-Canada's Boston Chapter and Nutter for a networking reception and life science panel discussion focusing on the importance of treating IP as a strategic business asset.  Key takeaways include:

  • Aligning IP with commercial objectives
  • Identifying overlooked IP landmines
  • Raising capital and preparing for exit
  • Managing IP spend
Speakers:

Jonathan Harris, Partner, Nutter

Todd Brady, CEO, Aldeyra Therapeutics

Romesh Subramanian, President and CEO, Marrow Therapeutics